EUROMCONTACT 2016 market data report on sales of contact lenses and lens care products is now available.

Brussels, 19th April 2017 

EUROMCONTACT 2016 market data report on sales of contact lenses and lens care products is now available. Since 2003, EUROMCONTACT provides the framework for statistics on market data and analysis, based on a collection and compilation of data from an independent company.  

The report “A Comparison of European Soft Contact Lens and Lens Care Markets in 2016”, from Euromcontact a.i.s.b.l is now available on-line.

In 2016, the market value of soft contact lenses (SCLs) at industry to eye care professionals (ECP) level grew by 5.7% to € 1’742 million. The market is defined as the 33 countries for which EUROMCONTACT collects data for Daily Disposables (DD), Weekly / Bi-Weekly and Monthly (W/B&M) and conventional soft (CS) CLs. Belgium was combined with Luxemburg, as was Ireland with the UK. Czech Republic and Slovakia are now reported separately. Hence there were 31 reported countries / clusters covering the 33 countries.

The CL market for the eleven reported countries in this paper grew by 4.8%, and the value was € 1’426 millions. The reported eleven countries represent 82.5% of the total collected. In the eleven countries, DD grew by +9.5%, W/B&M declined minimally (-0.14%). CS declined by 8.5%.

With a total of 15.2% (+9.7%) of the 15-64 years old population wearing CLs, Sweden is leading the penetration ranks, ahead of Denmark (13.1%, +4.9%) and Norway (11.1%, -5.2%)). Lowest among the eleven is Spain (4.1%, +4.3%), tied with Germany (4.1%; +3.6%).

Silicone Hydrogels (SiHy) are now at 83.6 % share in the W/B&M segment (across all 33 countries) and well above 60% in all of the reported eleven countries.

The total lens care market declined by 0.8% for all 33 countries/31 clusters. All countries had total data, but not all had data for all segments and all years.

EUROMCONTACT is the voice of European contact lens and lens care industry to the European Institutions, media, stakeholders and the public. EUROMCONTACT is the European Federation of National Associations and International Companies of Contact Lens and Lens Care Manufacturers. EUROMCONTACT members include National Associations of Manufacturers, representing Netherlands, Germany, Italy, Spain, Switzerland and the United Kingdom; the global companies Alcon, AMO Ltd., Bausch & Lomb, CooperVision, Johnson & Johnson Vision Care, Mark’ennovy, Menicon; and the European Federation for the Contact Lens Industry EFCLIN.


For further information, please contact:
Pascale Rouhier
Secretary General EUROMCONTACT aisbl
10, rue de Tamines
1060 Brussels-BE
Phone/Fax : +32 2 537 37 11  –

Newsflash 123

Newsletter 123 download

Read about:

  • EFCLIN Congress registration and hotel booking
  • Manufacturers’ Forum
  • Golf and Congress Dinner
  • 44th EFCLIN Congress and Exhibition lecture program
  • Charity with congress bags

EFCLIN Member Contamac announces appointment of Steve Morgan as Quality Manager

Contamac, the world’s largest and independent manufacturer of intraocular and contact lens materials, is delighted to announce the appointment of Steve Morgan as Quality Manager.

Contamac, the world’s largest manufacturer of Intraocular and Contact Lens materials are proud to announce the appointment of Steve Morgan as Quality Manager.  In this role Steve will assume full responsibility for Quality Assurance within the company, as well as providing a service to our customers to support their regulatory requirements. Steve joined Contamac from PA Consulting’s Technology Group, where he lead the quality organization in managing compliance to the company’s ISO 13485 and ISO 9001 certifications.  During his 12 years at PA, he also gained wide experience of managing the quality and regulatory aspects of medical device development projects, under both the EU MDD and US FDA regulations, covering products such as auto injectors and blood glucose meters.  Steve is also a lead assessor for the ISO 13485 and ISO 9001 standards, and has regularly undertaken third party quality audits on behalf of customers. Steve is delighted to have joined Contamac at a time when the company is continuing to enjoy significant growth across its product portfolio.  In his first 8 weeks with the company he has immersed himself in the business, covering all aspects of the internal production process, while starting to reach out and establish links with customers and trade organizations. Steve commented “My early impressions are extremely positive – the people at Contamac are a close knit team with a tremendous breadth of technical knowledge and understanding of the industry.  I have been made to feel very welcome in joining the organization and look forward to helping the company continue to manage the challenging quality and regulatory landscape ahead, which will help support both Contamac’s and their customers’ continued success.” Robert McGregor, Managing Director at Contamac said, “We are delighted to have Steve as part of the team, his extensive background and knowledge in the medical device industry will ensure that Contamac and its customers are as prepared as we can be to meet the ever increasing regulatory requirements placed upon our industry for the future.  This further demonstrates our commitment to quality and the desire to provide the best possible products to the industry.  Steve will add additional support to our customers and compliment the expertise we already provide through Research and Development, Technical support, Education and Sales and Marketing”.



Safer medical devices: Council adopts new EU rules

Latest Information from the Council of the EU

Press Release 7th March 2017

On 7 March 2017, the Council adopted new EU rules improving the safety of medical devices for the benefit of patients while preserving a timely access to innovative healthcare solutions.

Medical devices and in vitro diagnostic medical devices help diagnose, prevent and treat or alleviate diseases. They cover a wide range of products, from sticking plasters to hip replacements and hearing aids, and from pregnancy tests to HIV tests.

The new rules keep pace with recent technical developments. Their scope has been extended to cover certain products which do not have a specifically medical purpose, such as coloured contact lenses. The experience of metal-on-metal artificial hips and faulty silicone breast implants also has been taken into account in the preparation of the new rules, in particular by requiring the systematic scrutiny of vital implants by medical experts.

“Medical devices play a crucial role in all our lives. We all regularly use sticking plasters or have dental fillings, and we know people who are still alive thanks to devices that have helped in the diagnosis and treatment of serious diseases. These new rules will do more to help save lives, by having more innovative and safer devices on the market”

Mr Christopher Fearne, Minister for Health of Malta and President of the Council.

The two new EU regulations:

  • provide a stronger mandate to independent notified bodies in their assessment of medical devices before they can be placed on the market, and strengthen the oversight of these bodies by national authorities; the new rules also ensure that notified bodies meet the same high safety standards throughout the EU; these measures will improve the safety of medical devices
  • improve the availability of clinical data on devices and clearly set out manufacturers’ responsibilities for the follow-up of the quality, performance and safety of devices placed on the market; this will allow manufacturers to react quickly in the event of concerns being raised and help them improve their devices continuously on the basis of actual data
  • improve the traceability of medical devices throughout the supply chain to the end-user or patient by using a unique identification number; this will allow fast and effective measures to be taken in the event of safety problems
  • set up a central database to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU; this will enable them to make better informed decisions

Next steps

The European Parliament is expected to adopt the two regulations in April, after which they will be published in the Official Journal. The new rules will apply three years after publication as regards medical devices and five years after publication as regards in vitro diagnostic medical devices.

Regulation on medical devices

Regulation on in vitro diagnostic medical devices

Reform of the EU rules for medical and in vitro devices

Visit the Website

 Press contacts

Jérôme Unterhuber +32 22815394 / +32 473923628